D-0515-2019 Class III Terminated
FDA drug recall D-0515-2019 was initiated by Akorn Inc on Jan 25, 2019 and is designated Class III. Reason for recall: Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study. The recall status is terminated (terminated Nov 3, 2020). Affected quantity: a) 4896 tubes; b) 5064 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 27, 2019
- Initiation Date
- Jan 25, 2019
- Termination Date
- Nov 3, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 4896 tubes; b) 5064 tubes
Product description
Clobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60) tubes, Rx only. Manufacturer: Akorn Inc. 369 Bayview Ave., Amityville, NY 117701.
Reason for recall
Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.
Distribution pattern
Nationwide, including Puerto Rico.
Code information
a) 357052, exp 4/19/19 b) 356892, exp 4/16/19 and 356927, exp 4/15/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0515-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026